Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
SCNI

Market Cap: $350.81K

SL

Scinai Immunotherapeutics Ltd.

SCNI

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin-2.21%

EBITDA Margin-5.44%

EBIT Margin-6.51%

Pre-tax Margin-3.39%

Net Profit Margin-1.89%

Earnings Yield-10586.26%

Valuation Multiples

Price / Book0.00

Price / Sales0.25

Price / Earnings0.00

PEG-0.00

Forward PEG-0.00

EV / Sales0.52

EV / EBITDA-0.10

EV / Operating Cash Flow-0.11

EV / Free Cash Flow-0.11

Price / Free Cash Flow-0.05

Price / Operating Cash Flow-0.00

Cash Flow & Capital

Free Cash Flow / Share-$6,824.2

Operating Cash Flow / Share-$6,805.19

Free Cash Flow Yield-18.41%

Capex / Revenue1.27%

Capex / Operating Cash Flow-0.28%

Capex / Depreciation0.01

Stock Compensation / Revenue21.48%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.35

Quick Ratio1.35

Cash Ratio1.16

Debt / Assets0.20

Debt / Capital0.23

Debt / Equity0.30

Long-Term Debt / Capital0.02

Debt / Market Cap1.83%

Net Debt / EBITDA-0.05

Solvency Ratio-0.20

Financial Leverage1.50

Efficiency & Working Capital

Asset Turnover0.08

Fixed Asset Turnover0.10

Inventory Turnover0.00

Receivables Turnover9.43

Payables Turnover5.83

Days Sales Outstanding38.69

Days Inventory Outstanding0

Days Payables Outstanding62.57

Operating Cycle38.69

Cash Conversion Cycle-23.88

Working Capital Turnover2.02

Returns & Quality

Return on Equity-29.84%

Return on Assets-15.20%

Return on Invested Capital-53.23%

ROCE-54.49%

Return on Tangible Assets-15.20%

Operating Return on Assets-55.59%

Income Quality2.02

Tax Burden0.56

Interest Burden0.52

Balance Sheet & Intrinsic Metrics

Enterprise Value$732.81K

Invested Capital$14.9M

Working Capital$929.01K

Tangible Asset Value$11.76M

Net Current Asset Value$-2.21M

Graham Net-Net-$2,747.12

Book Value / Share$12,424.12

Tangible Book Value / Share$12,424.12

Cash / Share$3,289.58

Financial Health Scores

Piotroski Score4

Altman Z-Score-11.28

Revenue$1.42M

EBIT$-9.22M

Market Cap$361.86K

Working Capital$929.01K

Retained Earnings$-122.27M

Total Assets$17.59M

Total Liabilities$5.83M